FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to maieutics, and can be used for prediction of primary uterine inertia at primipara women. For this purpose conduct biochemical analysis of venous blood to determine parameters of the cellular energy exchange in 3-4 days before the expected date of childbirth. In blood serum is defined the total protein, albumin and lactate dehydrogenase, and also succinate dehydrogenase. Further determine a prognostic index by formula X=3.796-0.051A-0.026B-0.001C+0.57D, where X - a prognostic index; A - total protein, g/l; B - albumin, g/l; C- lactate dehydrogenase, g/l; D-SCK, standard units; Const = 3.796. At value X < 0 predicts a low risk of development of primary uterine inertia. At value X≥0 predicts a high risk of development of primary uterine inertia.
EFFECT: invention allows to reveal risk groups in due time.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING PRIMARY UTERINE INERTIA | 2016 |
|
RU2634039C1 |
| METHOD FOR PREDICTION OF PRIMARY HYPOTHONIC UTERINE DYSFUNCTION IN PRIMIPARA WOMEN | 2015 |
|
RU2623037C2 |
| METHOD OF PREDICTING UTERINE INERTIA | 2011 |
|
RU2478339C1 |
| METHOD FOR PREDICTION OF THE RISK OF DEVELOPING POOR UTERINE CONTRACTION STRENGTH IN WOMEN OF DIFFERENT SOMATOTYPES | 2019 |
|
RU2723596C1 |
| METHOD FOR PREDICTION OF COMPLICATED COURSE OF CHILDBIRTH IN YOUNG PRIMIPARA | 2020 |
|
RU2740803C1 |
| METHOD OF DELIVERY PREPARATION OF PREGNANT WOMEN AT HIGH RISK OF INITIAL UTERINE INERTIA | 2006 |
|
RU2324510C2 |
| METHOD FOR PREDICTION OF RISK OF INFECTIOUS-INFLAMMATORY COMPLICATIONS DEVELOPMENT IN WOMEN AFTER VERY EARLY PREMATURE DELIVERY | 2016 |
|
RU2632521C1 |
| METHOD FOR PREDICTING THE RISK OF UTERINE HYPOTENSION IN THE EARLY POSTPARTUM PERIOD IN WOMEN OF DIFFERENT SOMATOTYPES | 2021 |
|
RU2764952C1 |
| METHOD FOR CHOOSING THE TACTICS OF DELIVERY | 2000 |
|
RU2193198C2 |
| METHOD OF LABOR ACTIVITY PREDICTION | 1995 |
|
RU2132632C1 |
